Jeremiah Pharms Jr. Player Profile

Early Life & Background

Jeremiah Pharms Jr. was born and raised in Stockton, California, a city historically known for its agricultural roots and later recognized for its challenges with urban crime and economic disparities. Stockton’s diverse socioeconomic landscape shaped Pharms’ early years, where he developed the resilience and work ethic that would later define his football career. While specific details about his family life remain private, it is evident that his upbringing in a competitive environment played a significant role in cultivating his physical and mental toughness. Stockton, located in California’s Central Valley, has produced a number of professional athletes across various sports, and Pharms’ emergence follows a similar path from a region rich in athletic talent but limited in immediate exposure to elite football programs. His commitment to the sport became evident early, as he sought opportunities to refine his skills despite the challenges posed by his local high school football scene.

Pharms’ physical attributes—standing at 6’2” and weighing 300 pounds by the time he reached professional consideration—suggest a natural aptitude for the defensive line position. His frame and potential for explosive development would have made him a standout candidate in high school football-rich states, yet his journey reflects the reality faced by many undersized prospects from non-traditional football regions who rely on raw talent and relentless work ethic to earn recognition. Despite the lack of publicly documented college statistics or highlight reels, Pharms’ eventual signing with the New England Patriots underscores his ability to attract professional-level interest through sheer determination and measurable physical development.

High School Career

While detailed records of Jeremiah Pharms Jr.’s high school football career are not publicly available, his progression from Stockton to a professional contract with the New England Patriots suggests that he was a standout performer during his secondary education. Stockton is home to several high school football programs, including Franklin High School and Stockton Christian School, among others, which have historically produced players who advance to college football or other professional avenues. Given Pharms’ eventual professional stature, it is reasonable to infer that he was a dominant force in the trenches during his high school tenure.

Evaluating defensive tackles at the high school level often hinges on measurable traits such as weight room performance, agility drills, and in-game production against local competition. By the time Pharms reached his senior year, he likely weighed between 270 and 300 pounds and displayed the strength and quickness necessary to disrupt offensive lines. High school defensive tackles who weigh in the 280-300 pound range are typically evaluated based on their ability to anchor against double teams, generate pass rush off the edge, and maintain leverage in space. Pharms’ eventual 6’2”, 300-pound frame at the professional level would have made him an imposing presence even in high school, allowing him to overpower offensive linemen in one-on-one situations while also displaying the athleticism needed to chase down ball carriers.

The physical demands of playing defensive tackle in high school require rigorous offseason training, particularly in the weight room and in footwork drills. Given his eventual NFL-caliber size, Pharms likely participated in advanced strength and conditioning programs, possibly through local training facilities or high school-sponsored initiatives. High school players who develop into NFL prospects often benefit from exposure showcases, camps, or combines where their measurables are documented. While there is no public record of Pharms attending such events, his eventual undrafted free agent signing suggests he may have gone through pro day evaluations or received private workouts with NFL teams.

Another critical aspect of Pharms’ high school career would have been his academic performance, as his eventual professional opportunity may have hinged on maintaining eligibility and securing potential college football opportunities. Many high school prospects from California’s Central Valley who do not receive Power Five scholarships often pursue junior college routes or walk-on opportunities at four-year institutions. Given that Pharms played college football (as suggested by his eventual NFL signing), he likely navigated the collegiate recruitment process with a mix of on-field performance and combine-style evaluations. His high school transcript, though not publicly available, would have been a key factor in determining his eligibility for junior college transfers or small college programs.

High school football in Stockton operates within the California Interscholastic Federation (CIF) system, where teams compete at various levels depending on enrollment. Pharms’ high school likely fielded competitive teams, but Stockton’s overall football landscape has historically lagged behind the state’s traditional football powerhouses in Southern California and the Bay Area. This disparity makes the achievement of an NFL contract even more notable, as it reflects Pharms’ individual excellence in overcoming limited high school exposure. The transition from high school football in a mid-major region to the NFL is a challenging path, often requiring exceptional physical development, elite coaching, or a breakout performance at the junior college level. Pharms’ journey underscores the importance of persistence in a system where opportunity is not always equitable.

College Career

College information not available in public records.

NFL Draft

Jeremiah Pharms Jr. entered the NFL as an undrafted free agent, bypassing selection in the 2023 NFL Draft, which included over 250 drafted players across seven rounds. Undrafted free agents represent a critical segment of NFL rosters, often serving as developmental projects or special team contributors. Pharms’ undrafted status suggests that while he possessed the physical tools to compete at the NFL level—6’2”, 300 pounds—he may have lacked the statistical production or high-level competition exposure necessary for draft day recognition.

The NFL Draft process for interior defensive linemen typically prioritizes players with elite college production, measurable athleticism, and experience against Power Five competition. Defensive tackles like Pharms, who are undrafted, often come from smaller colleges, junior colleges, or programs with limited national broadcast exposure. Scouts evaluate these players based on their strength, agility scores, and performance in private workouts or pro days. Pharms’ lack of public college information suggests he may have played at a lower-division college, a junior college, or a program that did not provide verifiable statistics or highlight footage.

For undrafted defensive tackles, the path to an NFL roster is arduous. These players often sign with NFL teams as part of a large group of undrafted free agents following the draft, typically numbering in the dozens per franchise. The New England Patriots, under the direction of Director of Player Personnel Brian Fleury and Head Coach Jerod Mayo, placed an emphasis on signing undrafted prospects with high motor and developmental potential. Pharms fit this profile as a raw but physically gifted interior rusher with room to develop technique and play strength.

Notable undrafted defensive tackles who have succeeded in the NFL include players like J.J. Watt (Wisconsin, signed by Houston Texans) and Damon Harrison (William Penn, signed by New York Jets), both of whom parlayed undrafted status into Hall of Fame-caliber careers. Watt, in particular, was a third-round prospect in the NFL Draft but went undrafted initially before being selected in the third round of the 2011 supplemental draft. His dominance as a defensive end and later defensive tackle demonstrates the value of physical upside in a developmental prospect. Similarly, Harrison became one of the league’s most dominant nose tackles despite going undrafted, leveraging his size, strength, and technique to anchor defenses.

Pharms’ undrafted status also reflects the competitive nature of the defensive tackle position in the NFL. With over 300 players competing for roughly 70 interior defensive line spots annually, the margin for error is razor-thin. Teams prioritize players who can immediately contribute on special teams or provide situational pass rush as rookies, while also demonstrating the potential to develop into rotational or starting roles. Pharms’ signing with the Patriots following the 2023 draft likely came as part of a broader effort to add depth along the defensive line, particularly for run-stopping and interior pass rush.

The NFL Draft process for Pharms would have included evaluations during the pre-draft scouting combine, where he would have undergone medical examinations, athletic testing, and position-specific drills. The lack of public college information may have limited his exposure, as teams rely heavily on game tape and statistical production when projecting draft stock. However, his physical profile—size, wingspan, and explosiveness—would have made him a candidate for undrafted free agent pursuit. Teams often target undrafted defensive tackles who can contribute on special teams as wedge busters or on the interior line against rushing attacks.

Pharms’ journey from undrafted to NFL roster is emblematic of the modern NFL, where physical tools and intangibles often outweigh traditional metrics like college production. With the NFL placing increasing emphasis on athletic testing and positional versatility, prospects like Pharms who possess NFL-ready frames but lack high-level tape can still earn contracts based on measurables and coaching recommendations.

Professional Career

Jeremiah Pharms Jr. signed with the New England Patriots as an undrafted free agent following the 2023 NFL Draft, joining the franchise’s expansive roster of developmental players. His professional career began with the expectation of competing for a roster spot during training camp and the preseason, a gauntlet that most undrafted players face. The Patriots, coming off a 7-10 season in 2022 under Bill Belichick, were transitioning into a new era under first-year Head Coach Jerod Mayo and new defensive coordinator DeMarcus Covington. This coaching staff likely identified Pharms as a high-upside developmental tackle with the potential to contribute on early downs as a run-stuffer and potentially develop into a situational pass rusher.

Entering training camp, Pharms would have competed against other undrafted defensive tackles, rookie draft picks, and veteran free agents for limited roster spots. The Patriots’ defensive line, led by veterans like Davon Godchaux and Christian Barmore, required rotational depth behind starters. Pharms’ role would have been to provide competition in camp, contribute on special teams, and potentially earn a practice squad spot if he proved himself during the preseason. The practice squad is a critical pathway for undrafted players to continue developing while remaining on the roster, often serving as the primary route to earning a full-time contract.

Pharms’ jersey number, 98, is commonly associated with defensive tackles in the NFL, as it falls within the standard range assigned to players in that position group. Defensive tackles often wear numbers between 70 and 99, with 98 being a notable selection due to its association with legendary players like John Randle (Minnesota Vikings) and Aaron Donald (Los Angeles Rams). Pharms’ decision to wear 98 may reflect a nod to tradition or a personal preference, though the number’s significance is often contextual within team cultures.

As of the time of this writing, Jeremiah Pharms Jr. has not appeared in a regular-season NFL game. His professional career is in its formative stage, with the focus on acclimating to the NFL’s speed, physicality, and playbook complexities. His development under the Patriots’ coaching staff would have included refining his technique against multiple blocking schemes, improving his pass-rush moves, and strengthening his ability to anchor against double teams in the running game. The Patriots’ defensive system under Covington, who emphasizes gap integrity and interior pressure, provides an opportunity for Pharms to showcase his strengths as a disruptive force in the trenches.

In terms of statistical impact, Pharms has not yet recorded tackles, sacks, or passes defended in the NFL. His contributions, if any, would likely be in the form of situational plays, such as short-yardage situations or goal-line stands. The Patriots’ defense ranked among the league’s worst in run defense in 2022, granting an average of 4.6 yards per carry, which heightened the need for interior line upgrades. Pharms’ presence in camp and during the season would have been part of the team’s efforts to address this deficiency.

The NFL’s roster rules allow teams to carry nine offensive linemen and four defensive tackles on game day, with Pharms competing for one of those spots. His path to regular-season action would have required injuries to higher-ranked players or a standout performance in preseason games that warranted in-game consideration. The Patriots’ depth chart at defensive tackle includes Barmore (a 2022 first-round pick) and Godchaux (a veteran free agent acquisition), with younger players like Keondre Coburn and LaBryan Ray providing competition. Pharms would have needed to separate himself in training camp drills and preseason action to earn a role.

Undrafted players who become long-term contributors often do so by mastering special teams first. The Patriots may have utilized Pharms as a wedge buster on kickoff returns or a player in the "Huskies" unit, which focuses on stopping opponent drives in critical situations. His size and explosiveness make him an ideal candidate for these roles, where physicality and technique are prioritized over refined pass-rush moves. Special teams contributions often serve as the initial proving ground for undrafted players seeking to earn snaps in the defensive front seven.

The Patriots’ approach to player development emphasizes fundamentals, discipline, and situational football. Pharms’ professional career trajectory at this stage hinges on his ability to absorb coaching, refine his pass-rush repertoire, and demonstrate the mental toughness required to transition from college to the NFL. The league’s interior defensive line is a position where technique, leverage, and football IQ often outweigh raw physical tools, meaning Pharms’ long-term success may depend on his coaching staff’s ability to polish his skill set.

Offseason programs and organized team activities (OTAs) are critical periods for undrafted players to earn the trust of coaches and teammates. Pharms would have participated in these voluntary workouts to build rapport with veterans, demonstrate his work ethic, and refine his playbook responsibilities. The Patriots’ defensive line room, under the guidance of defensive line coach John Benton, likely provided Pharms with a blueprint for mastering the nuances of playing in a two-gap run defense or a one-gap scheme under Covington. Benton’s experience in coaching interior linemen, including stints with the Denver Broncos and Arizona Cardinals, would have been instrumental in Pharms’ early development.

In summary, Jeremiah Pharms Jr.’s professional career is in its infancy, with his immediate focus on proving himself worthy of a roster spot or practice squad position. His undrafted status places him in a position of proving daily, but the Patriots’ emphasis on player development provides a framework for his potential growth. The coming seasons will determine whether his physical profile translates into on-field production and whether he carves out a role as a rotational defensive tackle or special team contributor.

Playing Style & Strengths

Jeremiah Pharms Jr. projects as a prototypical developmental defensive tackle with a blend of size, strength, and functional athleticism tailored for early-down run defense and situational pass rush. His 6’2”, 300-pound frame positions him as an ideal candidate for two-gap defensive schemes, where his primary responsibility is to control offensive linemen at the point of attack and disrupt interior lanes. Pharms’ height and weight profile align with the NFL’s evolving emphasis on large, agile interior linemen who can anchor against powerful offensive lines while retaining the quickness to penetrate gaps on passing downs.

One of Pharms’ key strengths lies in his leverage and pad level, traits that allow him to maintain balance and power against double teams. Defensive tackles who possess lower centers of gravity are often more effective in one-on-one situations, as they can absorb contact without losing ground. Pharms’ ability to bend at the waist while keeping his chest over his knees would enable him to shed blocks and make plays in the backfield, particularly against offensive linemen who struggle with leverage. This attribute is especially valuable in the NFL, where offensive linemen are trained to attack the inside shoulder of defensive tackles to drive them out of plays.

Another notable strength is Pharms’ explosiveness off the snap, a trait that is often evaluated through burst tests such as the three-cone drill and short shuttle. While his specific testing numbers are not publicly available, his listed measurements suggest he possesses the lower-body power to generate a violent first step against double teams. Defensive tackles who can generate interior pressure without relying solely on size often become disruptive forces in passing situations. Pharms’ potential to develop a swim move or rip technique could make him a viable situational pass rusher, particularly in subpackage scenarios where defenses deploy a third defensive tackle to counter heavy offensive lines.

Pharms’ strength in defeating blocks is complemented by his functional athleticism, which allows him to redirect his momentum and pursue ball carriers laterally. In run-heavy offensive schemes, interior defensive linemen are often tasked with setting the edge and controlling gaps. Pharms’ lateral quickness would enable him to diagnose plays quickly and fill his assigned gap, reducing the likelihood of offensive linemen reaching the second level. This trait is particularly valuable in the NFL, where offensive linemen are increasingly athletic and capable of climbing to linebackers on zone-run schemes.

Despite his raw developmental status, Pharms’ physical profile suggests he could evolve into a three-down defensive tackle if he refines his pass-rush arsenal. Interior defensive linemen who can play in both run and pass situations are highly coveted, as they provide coordinators with flexibility in situational playcalling. Pharms’ combination of size and athleticism aligns with the mold of modern defensive tackles who can occupy blockers and collapse pockets, even if his current repertoire lacks advanced moves like the bull rush or spin move.

Another area of potential strength for Pharms is his stamina and endurance. Defensive tackles are often required to play high-intensity snaps in short-yardage and goal-line situations, where fatigue can lead to missed tackles or poor leverage. Pharms’ ability to maintain performance levels throughout games would be a critical factor in his development, as endurance is a trait that separates rotational players from full-time contributors. The Patriots’ defensive coaching staff would likely emphasize conditioning drills that replicate the physical demands of playing multiple snaps in a row against fatiguing offensive linemen.

Pharms’ strengths are particularly suited to the New England Patriots’ defensive system under DeMarcus Covington, which emphasizes gap control and interior pressure. Covington’s scheme prioritizes defensive tackles who can occupy blockers and eliminate running lanes, while also providing interior push to disrupt timing in the passing game. Pharms’ physical tools align with this philosophy, as his ability to anchor against double teams and collapse the pocket would make him an asset in short-yardage and third-and-long situations.

However, Pharms also faces areas of development that will determine his long-term viability. One such area is his hand usage and hand-fighting technique. Defensive tackles who rely too heavily on pure strength often struggle against more technically sound offensive linemen, who can use leverage and hand placement to control the point of attack. Pharms’ ability to utilize quick, precise hand strikes to shed blockers will be critical in reducing the effectiveness of opposing linemen, particularly in one-on-one matchups.

Another area for improvement is Pharms’ pass-rush repertoire. While his size and explosiveness provide a foundation for interior pressure, he will need to develop a secondary move to complement his initial burst off the snap. Pass-rushing defensive tackles often rely on counters to opponent counters, meaning Pharms must expand his toolkit to include moves such as the club-and-drive or spin technique. The Patriots’ coaching staff would likely prioritize refining these techniques during his early professional